Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ThreeD Capital Inc. Announces Investor Relations Agreement
-
Telix Announces Planned Registered Public Offering and Listing in the United States
-
Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
-
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
-
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
-
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025
-
Axogen Announces Promotions on Research and Development Team
-
PolyPid Announces Private Placement for $16 Million in Gross Proceeds
-
REVIV3 Procare Company Reports Record Second Quarter Fiscal Year 2024 Financial Results
-
Kernel Group Holdings, Inc. Confirms Funding to Extend Period to Consummate Initial Business Combination
-
Old National Bancorp Announces Schedule for Fourth-Quarter and Full-Year 2023 Earnings Release and Conference Call
-
Volaris Reports December 2023 Traffic Results: 85% Load Factor
-
Micron Solutions, Inc. Announces Completion of Stock Splits
-
Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
NuLegacy Suspends 2024 Exploration Program
-
Costco Wholesale Corporation Reports December Sales Results
-
DoubleDown Interactive to Participate in iAccess Alpha Virtual MicroCap Conference on January 9th and 10th
-
Enact to Host Fourth Quarter 2023 Earnings Call February 7th
-
ETC’s Aerospace Segment Awarded $12.4 Million in Contracts
-
Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lym
-
Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System
-
Costco Wholesale Corporation Reports December Sales Results
-
DoubleDown Interactive to Participate in iAccess Alpha Virtual MicroCap Conference on January 9th and 10th
-
Compass Diversified Declares Fourth Quarter 2023 Distributions on Common and Series A, B and C Preferred Shares
-
Voyager Therapeutics Announces Proposed Public Offering
-
Candelaria Announces Change in Chief Financial Officer
-
National Bank Holdings Corporation Announces Date for 2023 Fourth Quarter Earnings Release
-
CTO Realty Growth Announces 2023 Transaction and Leasing Activity and Provides Share Repurchase Update
-
Alpine Income Property Trust Announces 2023 Transaction Activity and Provides Corporate Update
-
Park Aerospace Corp. Announces Date of Third Quarter Earnings Release and Conference Call
-
PennantPark Investment Corporation Schedules Earnings Release of First Fiscal Quarter 2024 Results
-
PennantPark Floating Rate Capital Ltd. Schedules Earnings Release of First Fiscal Quarter 2024 Results
-
Great Lakes Provides Update on Empire Wind I and II Contracts
-
Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma
-
Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directors
-
Kura Sushi USA Announces Fiscal First Quarter 2024 Financial Results
-
scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue
-
Brookline Bancorp, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call
-
Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer
-
Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC
-
Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy
-
Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024
-
Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma
-
Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference
-
Trio Petroleum Corp Announces the Restart of the McCool Ranch Oil Field
-
Port of Oakland, Parsons and Partners Launch New App to Improve Port Operations
-
Joseph Guiliano appointed Chief IP Officer of Adeia
-
Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical Officer
-
Aeries Technology to Participate at the 26th Annual ICR Conference
-
Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference
